Japan · Delayed Price · Currency is JPY Renascience Statistics
Total Valuation
Renascience has a market cap or net worth of JPY 18.03 billion. The enterprise value is 14.83 billion.
| Market Cap | 18.03B |
| Enterprise Value | 14.83B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Renascience has 13.78 million shares outstanding. The number of shares has increased by 3.41% in one year.
| Current Share Class | 13.78M |
| Shares Outstanding | 13.78M |
| Shares Change (YoY) | +3.41% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 21.08% |
| Owned by Institutions (%) | -3.20% |
| Float | 10.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 265.21 |
| PB Ratio | 5.57 |
| P/TBV Ratio | 5.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 218.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 62.13
| Current Ratio | 62.13 |
| Quick Ratio | 60.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.96% and return on invested capital (ROIC) is -8.61%.
| Return on Equity (ROE) | -12.96% |
| Return on Assets (ROA) | -8.38% |
| Return on Invested Capital (ROIC) | -8.61% |
| Return on Capital Employed (ROCE) | -10.40% |
| Weighted Average Cost of Capital (WACC) | 13.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Renascience has paid 1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.95% in the last 52 weeks. The beta is 1.70, so Renascience's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -39.95% |
| 50-Day Moving Average | 1,473.12 |
| 200-Day Moving Average | 1,609.27 |
| Relative Strength Index (RSI) | 44.46 |
| Average Volume (20 Days) | 510,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renascience had revenue of JPY 68.00 million and -317.00 million in losses. Loss per share was -24.12.
| Revenue | 68.00M |
| Gross Profit | 64.00M |
| Operating Income | -337.00M |
| Pretax Income | -316.00M |
| Net Income | -317.00M |
| EBITDA | n/a |
| EBIT | -337.00M |
| Loss Per Share | -24.12 |
Balance Sheet
The company has 3.20 billion in cash and no debt, with a net cash position of 3.20 billion or 232.56 per share.
| Cash & Cash Equivalents | 3.20B |
| Total Debt | n/a |
| Net Cash | 3.20B |
| Net Cash Per Share | 232.56 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 235.18 |
| Working Capital | 3.24B |
Cash Flow
| Operating Cash Flow | -291.00M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -291.00M |
| FCF Per Share | -21.12 |
Margins
| Gross Margin | 94.12% |
| Operating Margin | -495.59% |
| Pretax Margin | -464.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Renascience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.41% |
| Shareholder Yield | -3.41% |
| Earnings Yield | -1.76% |
| FCF Yield | -1.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Renascience has an Altman Z-Score of 276.67 and a Piotroski F-Score of 2.
| Altman Z-Score | 276.67 |
| Piotroski F-Score | 2 |